In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

(MedPage Today) — NEW ORLEANS — This weekend, catheter-based therapies have potentially practice-changing trial results expected at the American College of Cardiology (ACC) annual conference.
Kicking off the opening late-breaking clinical…

Source link : https://www.medpagetoday.com/meetingcoverage/acc/120506

Author :

Publish date : 2026-03-26 18:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

Dupilumab May Simplify Chronic Spontaneous Urticaria Treatment

Here’s What People Want on ‘The Pitt’ Season 3

Related Posts

Can GLP-1 Drugs Prevent Worsening Mental Illness? Perhaps, Study Suggests

Indian Health Service Prepping to Break Ground to Replace Aging Medical Buildings

Plunge in Antiviral Scripts for Hep C Points to Unmet Treatment Needs

Survey Examines Current Practice in Skin of Color Clinics

Pediatrician Who Traded Drugs for Sex Gets 20 Years in Prison

A Ubiquitous Alcohol Emerges as Allergen of 2026

Can GLP-1 Drugs Prevent Worsening Mental Illness? Perhaps, Study Suggests

Indian Health Service Prepping to Break Ground to Replace Aging Medical Buildings

Plunge in Antiviral Scripts for Hep C Points to Unmet Treatment Needs

Survey Examines Current Practice in Skin of Color Clinics

Pediatrician Who Traded Drugs for Sex Gets 20 Years in Prison

A Ubiquitous Alcohol Emerges as Allergen of 2026

Utah Is the New U.S. Hotspot for Measles

FDA Signals Regulatory Flexibility With Accelerated Approval of Rare Disease Drug

Categories

Archives